DrugPatentWatch Database Preview
Drugs in Development Information for Trafermin
» See Plans and Pricing
What is the drug development status for Trafermin?
Trafermin is an investigational drug.
There have been 6 clinical trials for Trafermin.
The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2008.
The most common disease conditions in clinical trials are Periodontitis, Diabetic Foot, and Ulcer. The leading clinical trial sponsors are Kaken Pharmaceutical, Olympus Biotech Corporation, and [disabled in preview].
Summary for Trafermin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2008-08-01) |
| Vendors | 0 |
Recent Clinical Trials for Trafermin
| Title | Sponsor | Phase |
|---|---|---|
| The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study | Olympus Biotech Corporation | Phase 3 |
| The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study | Olympus Biotech Corporation | Phase 3 |
| A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3) | Kaken Pharmaceutical | Phase 3 |
Clinical Trial Summary for Trafermin
Top disease conditions for Trafermin
Top clinical trial sponsors for Trafermin
US Patents for Trafermin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
